Skip to main content

Table 2 Demographics, clinical and pathological characteristics of biliary tract cancer patients

From: Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling

Total number of BTC patients

39

Males

24

Females

15

Cholangiocarcinoma

37

Gallbladder carcinoma

2

Positive cytology

17

Positive histology:

22

  Poorly-differentiated

11

  Moderately-differentiated

10

  Well-differentiated

1

Intrahepatic cholangiocarcinoma

2

Extrahepatic cholangiocarcinoma:

35

  Hilar

31

  Distal bile duct

4

Stage:

 

  T1 or T2

18

  T3 or T4

21

Deaths

33/39 (85%)

Median survival and range (months)

8.4 (1.4-43.9)